Guggenheim Capital’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-5,582
Closed -$323K – 2311
2018
Q3
$323K Buy
5,582
+1,270
+29% +$71.2K ﹤0.01% 2185
2018
Q2
$245K Sell
4,312
-13,418
-76% -$764K ﹤0.01% 2251
2018
Q1
$1.04M Sell
17,730
-1,979
-10% -$111K ﹤0.01% 2053
2017
Q4
$1.08M Buy
+19,709
New +$1.02M ﹤0.01% 2038
2017
Q3
– Sell
-5,175
Closed -$242K – 2833
2017
Q2
$242K Sell
5,175
-4,308
-45% -$179K ﹤0.01% 2603
2017
Q1
$363K Sell
9,483
-6,447
-40% -$239K ﹤0.01% 2502
2016
Q4
$576K Sell
15,930
-3,350
-17% -$127K ﹤0.01% 2372
2016
Q3
$824K Sell
19,280
-5,726
-23% -$256K ﹤0.01% 2177
2016
Q2
$1.06M Sell
25,006
-2,442
-9% -$106K ﹤0.01% 2024
2016
Q1
$1.14M Sell
27,448
-4,857
-15% -$190K ﹤0.01% 1965
2015
Q4
$1.27M Sell
32,305
-3,648
-10% -$136K ﹤0.01% 1962
2015
Q3
$1.21M Sell
35,953
-1,396
-4% -$49.7K ﹤0.01% 1974
2015
Q2
$1.24M Buy
37,349
+11,652
+45% +$401K ﹤0.01% 2110
2015
Q1
$923K Buy
25,697
+8,460
+49% +$266K ﹤0.01% 2279
2014
Q4
$518K Buy
17,237
+4,064
+31% +$119K ﹤0.01% 2521
2014
Q3
$408K Buy
13,173
+3,124
+31% +$104K ﹤0.01% 2629
2014
Q2
$365K Buy
10,049
+731
+8% +$23.6K ﹤0.01% 2705
2014
Q1
$281K Buy
+9,318
New +$215K ﹤0.01% 2765

Other funds holding OFIX

Guggenheim Capital's OFIX Position: Q4 2018 in Review

Guggenheim Capital sold out of Orthofix Medical (OFIX) in Q4 2018, closing a stake of 5,582 shares — an estimated $323K sold.

Guggenheim Capital first reported a position in OFIX in Q1 2014 and held it in 18 quarters. The position peaked at $1.27M in Q4 2015. 171 funds tracked by Wall St. Rank hold OFIX as of Q4 2018.

  • Guggenheim Capital reported no remaining Orthofix Medical position as of Q4 2018 after selling out during the quarter.
  • Guggenheim Capital sold 5,582 Orthofix Medical shares in Q4 2018, an estimated $323K.
  • Guggenheim Capital first reported a position in Orthofix Medical in Q1 2014 and held it in 18 quarters.
  • Guggenheim Capital's Orthofix Medical position peaked at $1.27M in Q4 2015.
  • 171 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2018.

Based on Guggenheim Capital's 13F filing for Q4 2018, filed 14 Feb 2019.